Skip to main content

Simple (Benign) Nephrectomy

Simple nephrectomy is removal of the kidney within (or under) Gerota's fascia for benign indications — without perirenal-fat excision, ipsilateral adrenalectomy, or regional lymphadenectomy. The BAUS Nephrectomy Database authors propose the more accurate term "benign nephrectomy", because the inflammatory and fibrotic changes that drive the indication routinely make the operation technically harder than radical nephrectomy for a T1 cancer.[1][2][3]

The defining anatomic distinction is the dissection plane: simple nephrectomy works directly on the renal capsule or within Gerota's fascia, whereas radical nephrectomy stays outside Gerota's fascia. The clean Gerota's plane that makes the radical operation predictable is the very thing that benign disease destroys.[1][3][2]

Indications​

Non-functioning kidney (most common)​

A non-functioning kidney (NFK) is generally defined as one with split renal function <10–15% on nuclear renography.[4] Etiologies in large series:[5][1]

  • Ureteropelvic junction obstruction — single most common cause (39% of Gupta n = 505).
  • Calculus disease — 38%.
  • Chronic pyelonephritis / pyonephrosis.
  • Vesicoureteral reflux with reflux nephropathy.
  • Genitourinary tuberculosis — 9.5%.
  • Renal dysplasia / anomalous kidney.

In the UK BAUS series (n = 1,093), non-functioning kidneys accounted for 49%, other benign conditions 26%, stone disease 13%, and pyelonephritis 12%.[1]

Stone disease​

Indicated when stone disease has caused irreversible parenchymal damage with non-function — staghorn calculi with chronic infection, recurrent stone formation in a non-functioning kidney, or failed prior interventions.

Stone disease carries the highest complication rate of any benign indication: intraoperative complications 9.9% and postoperative 23.9%.[1]

In a safety-net hospital series, stone disease was the leading medical contributor (55.3%), followed by retained ureteral stent (30.6%) and stricture (30.6%). The operating surgeon judged 38.8% of cases preventable had the underlying conditions been addressed earlier.[7]

Xanthogranulomatous pyelonephritis (XGP)​

Destructive chronic pyelonephritis with replacement of parenchyma by lipid-laden xanthoma cells. Systematic review of >1,000 cases:[8][9]

  • Mean age 49; 70% female; 28% diabetic.
  • 69% have stones (48% staghorn).
  • Correctly diagnosed preoperatively only 45% of the time — frequently mistaken for renal neoplasm.
  • Fistulae in 8%.
  • Total nephrectomy is the definitive treatment; partial nephrectomy feasible in only 2% (focal XGP).
  • Perioperative mortality 1.4%.

Long-term preoperative antibiotics (≥28 days) before laparoscopic nephrectomy for XGP shortened length of stay by 6.5 days and significantly reduced the number and severity of postoperative complications (p = 0.001).[10]

Renovascular hypertension​

Selected patients with renal artery stenosis who develop a small atrophic non-functioning kidney contributing to treatment-resistant hypertension after revascularization failure. Mayo Clinic n = 74, mean follow-up 4.1 years (mean long axis 8 cm, mean function 12%):[12]

  • Systolic BP fell from 168 to 136 mmHg (p < 0.001).
  • Cure or improvement of hypertension in the majority.
  • Two-thirds of hypertensive patients with severe unilateral disease benefited.

Genitourinary tuberculosis​

ATS/CDC/IDSA: nephrectomy is considered for a non-functioning or poorly functioning kidney, particularly with hypertension or persistent flank pain, after at least 6 weeks of intensive antituberculous chemotherapy.[14][15][16]

In the landmark Skutil/Obsitník series of 300 GU TB patients, 21.7% required nephrectomy. The most common indication was persistent tuberculous cystitis (62%), followed by chronic infection/calcification (13.1%) and suspected nephrogenic hypertension (11.7%); two-thirds of hypertensive patients benefited from nephrectomy.[15][17]

Autosomal dominant polycystic kidney disease (ADPKD)​

Per KDIGO 2025, native nephrectomy in ADPKD is performed only for specific indications when benefit outweighs risk:[18][19][20][21]

  • Severe symptoms from massively enlarged kidneys (mass effect).
  • Recurrent or severe infection or bleeding.
  • Complicated nephrolithiasis.
  • Intractable pain.
  • Suspicion of renal cell carcinoma.
  • Insufficient space for a kidney graft.
  • Severe ventral hernia.

Key principles:

  • Time the nephrectomy at or after transplantation, not before — minimizes transfusion risk, avoids delaying preemptive transplantation, and reduces complications.
  • Hand-assisted laparoscopic nephrectomy is preferred over open.
  • Up to ~20% of ADPKD patients eventually require nephrectomy.
  • ERA 2025 consensus confirms nephrectomy is an intermediate-risk procedure with acceptable mortality and minimal impact on graft function.

Other benign indications​

  • Chronic pain from a non-functioning kidney.
  • Recurrent UTI from a non-functioning kidney serving as an infection nidus.
  • Failed prior reconstruction (e.g., failed pyeloplasty).
  • Renal hypoplasia / dysplasia.
  • Multicystic dysplastic kidney (when symptomatic).
  • Iatrogenic ureteral injury producing a non-functioning kidney.[3][5]

Surgical Approaches​

Open simple nephrectomy​

Reserved for cases in which MIS is contraindicated or has failed.

Flank (retroperitoneal) approach.

  • Lateral decubitus, affected side up.
  • Incision over the 11th or 12th rib, posterior axillary line to anterior axillary line.
  • Divide external oblique, internal oblique, transversus abdominis.
  • Open Gerota's; mobilize the kidney within or on the capsule.
  • Identify the hilum; ligate and divide renal artery and vein individually.
  • Divide the ureter as distally as feasible.
  • Direct retroperitoneal access without entering the peritoneum or manipulating bowel.
  • The posterior lumbotomy (Novick) is excellent for bilateral nephrectomy, simple nephrectomy for benign disease, and pyeloplasty.[22]

Transperitoneal (anterior subcostal) approach. Wider exposure for larger kidneys or when additional abdominal exploration is needed; requires bowel mobilization.[23]

Open nephrectomy has shorter operative time than laparoscopic (mean 70 vs 85 min) but greater blood loss (170 vs 110 mL), longer LOS (5 vs 3 d), and longer convalescence.[5]

Laparoscopic simple nephrectomy​

Standard of care for benign nephrectomy — performed in 76% of cases in the UK BAUS database.[1]

Transperitoneal. Lateral decubitus; 3–4 ports along anterior axillary and midclavicular lines; reflect colon medially (Toldt); control hilum with clips, staples, or sutures; specimen retrieved via morcellation or extended port-site incision.

Retroperitoneal. Lateral decubitus or prone; balloon-dilate the retroperitoneal space; 3 posterior ports; direct hilar access without bowel mobilization. Particularly useful for inflammatory kidneys (avoids peritoneal contamination) and patients with prior abdominal surgery.[24][5]

The largest retroperitoneoscopic series (Gupta n = 505):[5]

  • Successful completion 94.2% (25 conversions to open).
  • Mean OR time 85 min; mean blood loss 110 mL.
  • Transfusion rate 0.8% (vs 4.5% open).
  • Mean LOS 3 d (vs 5 d open).

Robotic simple nephrectomy​

Emerging alternative, particularly attractive for complex inflammatory cases. Rogers n = 7: all completed robotically, no conversions, mean console time 158 min, mean LOS 2.4 d.[25] Robotic simple nephrectomy may reduce open-conversion rates vs standard laparoscopy in infected cases due to enhanced dexterity and visualization.[2]

Subcapsular nephrectomy​

When severe perirenal inflammation makes extracapsular dissection hazardous (XGP, pyonephrosis, TB), the renal capsule is incised and the kidney dissected within the capsule, leaving the capsule adherent to surrounding structures. Hilar vessels are controlled from within the capsule. Used in 6/52 (11.5%) pyonephrotic kidneys in one series.[26][27][28]

Why Benign Nephrectomy Is Harder Than Radical​

ParameterSimple (Benign)Radical (T1 Cancer)
Intraoperative complications5.2%3.7%
Postoperative complications11.9%10.0%
Conversion to open (MIS)5.9% (1.8× higher)3.3%
Blood transfusion4.8%2.8%
Operative timeLonger (p = 0.001)Shorter
Length of stayLonger (p = 0.049)Shorter

References:[1][2]

The reasons are anatomic, not oncologic:[1][3][2][31]

  1. Perirenal fibrosis and adhesions from chronic inflammation obliterate tissue planes.
  2. Hilar lymphadenopathy obscures vascular anatomy.
  3. Pyonephrosis / abscess raises contamination and sepsis risk.
  4. Prior surgery / nephrostomy introduces dense scarring.
  5. Loss of the Gerota's-fascia plane that makes the radical operation predictable.

Infected simple nephrectomies are particularly demanding (significantly increased OR time, blood loss, conversion rate, and LOS).[2] Conversion is highest for XGP (28%), followed by pyonephrosis and calculus pyelonephritis.[31][32]

Complications​

Overall (BAUS n = 1,093):[1]

  • Intraoperative 5.2%; postoperative 11.9%; blood loss >500 mL 6.8%; transfusion 4.8%; MIS conversion 5.9%.

By pathology:[1]

PathologyIntraoperativePostoperative
Stone disease9.9%23.9%
Pyelonephritis5.4%14.0%
Non-functioning kidney4.3%9.3%
Other benign4.6%9.5%

Specific complications to anticipate:[31][23][33][3][32]

  • Vascular injury — renal vein or IVC injury, particularly on the right side with inflammatory hilar adhesions; the most feared intraoperative complication.
  • Visceral injury — colonic (more common laparoscopically), splenic (left), duodenal (right).
  • Pleural entry — more common with the open flank approach.
  • Wound complications — flank bulge ~4%, hernia, wound infection.
  • Postoperative bleeding — may require transfusion or re-exploration.
  • Ileus — particularly with the transperitoneal approach.

Emergency nephrectomy for surgical pyelonephritis​

In a recent series of 88 patients with surgical pyelonephritis (pyonephrosis, renal/perinephric abscess, emphysematous pyelonephritis), 10 underwent primary emergency nephrectomy and 9 required secondary nephrectomy after failed conservative management. Diabetes, high ASA score, CKD, and smoking were associated with conservative-management failure.[34]

Long-Term Renal Function​

Simple nephrectomy is functionally different from radical nephrectomy because the kidney being removed is usually already non-functioning and the contralateral kidney has had time to compensate.[35]

  • GFR decline after simple nephrectomy: 6% vs radical nephrectomy: 29% (p < 0.001).
  • Postoperative GFR is significantly higher after simple nephrectomy at all time points (1 d, 1 mo, 1 yr, last follow-up).
  • Mechanism: gradual functional loss of the diseased kidney drives compensatory hypertrophy of the contralateral kidney before surgery.

A meta-analysis of 48 studies (n = 3,124) found that unilateral nephrectomy caused a GFR decrement of −17.1 mL/min that improved over time (+1.4 mL/min per decade); in normal individuals (e.g., kidney donors) it does not cause progressive renal dysfunction but is associated with a small rise in systolic BP (+2.4 mmHg).[36]

Preoperative Optimization​

For inflammatory or infected kidneys:[5][10][14][15][16][38][4]

  • Percutaneous nephrostomy to drain pyonephrosis or obstructed infected systems before definitive nephrectomy. 33/36 pyonephrotic patients had preoperative PCN in the Gupta series.
  • Preoperative antibiotics ≥4 weeks for XGP (LOS 6.5 d shorter, fewer complications).
  • At least 6 weeks of intensive antituberculous chemotherapy before nephrectomy for renal TB.
  • CT with contrast to map perirenal inflammation, hilar anatomy, adjacent organ involvement, vascular anomalies.
  • Nuclear renography to confirm non-function (<10–15% split function).

For ADPKD:[18]

  • Cross-sectional imaging within 1 year of anticipated transplantation to rule out solid or complex cystic lesions.
  • Subtract estimated total kidney and liver weights from body weight for accurate BMI assessment.

Approach Selection​

Clinical scenarioPreferred approachRationale
Elective non-inflammatory NFKRetroperitoneoscopic or laparoscopicGold standard; shortest recovery.[1][2]
Inflammatory kidney (XGP, pyonephrosis)Retroperitoneoscopic (experienced surgeon) or openAvoids peritoneal contamination; low threshold for conversion.[3][31]
Prior ipsilateral surgery / nephrostomyRetroperitoneoscopic preferredAvoids intraperitoneal adhesions.[5]
ADPKD (massively enlarged)Hand-assisted laparoscopicAllows specimen extraction; handles large kidneys.[18][21]
Renal TBRetroperitoneoscopic or open after ≥6 wk chemotherapySubcapsular if severe adhesions.[14][27]
Emergency (sepsis, emphysematous PN)Open (often)Speed and safety; high MIS-conversion rate.[34]
PediatricMIS (any approach)Gold standard; comparable to open with fewer complications.[48]

Special Populations​

Pediatric​

MIS is now the gold standard. In a 213-nephrectomy comparison (single-instrument retroperitoneoscopic, two-instrument retroperitoneoscopic, transperitoneal, and open), MIS approaches had significantly fewer intraoperative complications (p = 0.03) with comparable OR time and LOS. No conversions occurred in the retroperitoneoscopic groups.[48]

Elderly​

In a 20-year series of 646 consecutive nephrectomies, nephrectomy for benign conditions had a significantly lower complication rate than for malignant disease (p < 0.05), and laparoscopic approaches had lower morbidity than open in elderly cohorts.[49]

Social determinants​

In a safety-net hospital series, social factors contributing to simple nephrectomy included lack of insurance (58.5%), substance abuse (32.3%), mental health (24.6%), and immigration status (18.5%). The authors framed simple nephrectomy as potentially representing a "failure of management" of underlying conditions — awareness can guide prevention strategies.[7]

Outcomes Summary​

SeriesnApproachOR timeEBLConversionLOSComplications
BAUS UK 2016[1]1,09376% MISNR>500 mL in 6.8%5.9%NR5.2% intra / 11.9% post
Gupta 2008[5]505Retroperitoneoscopic85 min110 mL5.0%3 d0.8% transfusion
Hemal 2001[26]185Retroperitoneoscopic100 min133 mL9.7%3 d16.2% minor / 3.8% major
Papadopoulou 2024[2]129MixedLonger than RNSimilarSimilarLonger than RNHigher than RN
Hsiao 2008[3]42Laparoscopic202.5 min100 mL7.1%Variable21.4%
Parra 1995[6]12Laparoscopic145 minNR8.3%3.5 d16.7%

See Also​

References​

1. Zelhof B, McIntyre IG, Fowler SM, et al. Nephrectomy for benign disease in the UK: results from the British Association of Urological Surgeons Nephrectomy Database. BJU Int. 2016;117(1):138–144. doi:10.1111/bju.13141

2. Papadopoulou A, Campain N, Abu-Ghanem Y, et al. Not-so-simple nephrectomy: comparative analysis of radical and simple nephrectomy in a high-volume tertiary referral center. Int J Urol. 2024;31(2):160–168. doi:10.1111/iju.15330

3. Hsiao W, Pattaras JG. Not so "simple" laparoscopic nephrectomy: outcomes and complications of a 7-year experience. J Endourol. 2008;22(10):2285–2290. doi:10.1089/end.2008.9718

4. Rai RK, Pandey A, Verma S, et al. Management of non-functioning kidney due to pelvi-ureteric junction obstruction in pediatric age group: an observational study. Pediatr Surg Int. 2023;39(1):85. doi:10.1007/s00383-023-05368-3

5. Gupta NP, Hemal AK, Mishra S, Dogra PN, Kumar R. Outcome of retroperitoneoscopic nephrectomy for benign nonfunctioning kidney: a single-center experience. J Endourol. 2008;22(4):693–698. doi:10.1089/end.2007.0267

6. Parra RO, Perez MG, Boullier JA, Cummings JM. Comparison between standard flank versus laparoscopic nephrectomy for benign renal disease. J Urol. 1995;153(4):1171–1173; discussion 1173–1174.

7. Ames KS, Baky F, Blair S, et al. Simple nephrectomy in a tertiary care safety net hospital — patient characteristics, causes, cost, and renal function implications. Urology. 2021;149:98–102. doi:10.1016/j.urology.2020.12.013

8. Harley F, Wei G, O'Callaghan M, et al. Xanthogranulomatous pyelonephritis: a systematic review of treatment and mortality in more than 1000 cases. BJU Int. 2023;131(4):395–407. doi:10.1111/bju.15878

9. Jang TL, McKoy T, Hakim J, Polenakovik HM. Xanthogranulomatous pyelonephritis — a diagnostic and therapeutic dilemma. Am J Med Sci. 2023;365(3):294–301. doi:10.1016/j.amjms.2022.11.004

10. Xie L, Tapiero S, Flores AR, et al. Long-term antibiotic treatment prior to laparoscopic nephrectomy for xanthogranulomatous pyelonephritis improves postoperative outcomes: results from a multicenter study. J Urol. 2021;205(3):820–825. doi:10.1097/JU.0000000000001429

12. Kane GC, Textor SC, Schirger A, Garovic VD. Revisiting the role of nephrectomy for advanced renovascular disease. Am J Med. 2003;114(9):729–735. doi:10.1016/s0002-9343(03)00161-x

14. Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63(7):e147–e195. doi:10.1093/cid/ciw376

15. Flechner SM, Gow JG. Role of nephrectomy in the treatment of non-functioning or very poorly functioning unilateral tuberculous kidney. J Urol. 1980;123(6):822–825. doi:10.1016/s0022-5347(17)56149-2

16. Carl P, Stark L. Indications for surgical management of genitourinary tuberculosis. World J Surg. 1997;21(5):505–510. doi:10.1007/pl00012277

17. Skutil V, Obsitník M. Persistent tuberculous cystitis: the most common indication for nephrectomy in the management of urogenital tuberculosis. Eur Urol. 1987;13(1–2):57–61.

18. Torres VE, Ahn C, Barten TRM, et al. KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Executive Summary. Kidney Int. 2025;107(2):234–254. doi:10.1016/j.kint.2024.07.010

19. Geertsema P, Gansevoort RT, Arici M, et al. Nephrectomy in autosomal dominant polycystic kidney disease: a consensus statement of the ERA Genes & Kidney Working Group. Nephrol Dial Transplant. 2025;40(5):1032–1054. doi:10.1093/ndt/gfaf019

20. Ong ACM, Carriazo S, Ma BM, Torra R, Pei Y. Autosomal dominant polycystic kidney disease. Lancet. 2026;407(10535):1289–1302. doi:10.1016/S0140-6736(26)00046-2

21. Thomas MN, Datta RR, Wahba R, et al. Introduction of laparoscopic nephrectomy for autosomal dominant polycystic kidney disease as the standard procedure. Langenbecks Arch Surg. 2023;408(1):8. doi:10.1007/s00423-022-02737-9

22. Novick AC. Posterior surgical approach to the kidney and ureter. J Urol. 1980;124(2):192–195. doi:10.1016/s0022-5347(17)55369-0

23. Anastasiou J, Karatzas T, Felekouras E, et al. Radical nephrectomy with transperitoneal subcostal incision for large and locally advanced tumors of the right kidney. Anticancer Res. 2012;32(11):5023–5029.

24. Gupta NP, Goel R, Hemal AK, et al. Should retroperitoneoscopic nephrectomy be the standard of care for benign nonfunctioning kidneys? An outcome analysis based on experience with 449 cases in a 5-year period. J Urol. 2004;172(4 Pt 1):1411–1413. doi:10.1097/01.ju.0000138371.46317.7a

25. Rogers C, Laungani R, Krane LS, et al. Robotic nephrectomy for the treatment of benign and malignant disease. BJU Int. 2008;102(11):1660–1665. doi:10.1111/j.1464-410X.2008.07895.x

26. Hemal AK, Gupta NP, Wadhwa SN, Goel A, Kumar R. Retroperitoneoscopic nephrectomy and nephroureterectomy for benign nonfunctioning kidneys: a single-center experience. Urology. 2001;57(4):644–649. doi:10.1016/s0090-4295(00)01059-1

27. Zhang X, Zheng T, Ma X, et al. Comparison of retroperitoneoscopic nephrectomy versus open approaches to nonfunctioning tuberculous kidneys: a report of 44 cases. J Urol. 2005;173(5):1586–1589. doi:10.1097/01.ju.0000154624.44403.b9

28. Hemal AK, Mishra S. Retroperitoneoscopic nephrectomy for pyonephrotic nonfunctioning kidney. Urology. 2010;75(3):585–588. doi:10.1016/j.urology.2008.07.054

31. Duarte RJ, Mitre AI, Chambô JL, Arap MA, Srougi M. Laparoscopic nephrectomy outside Gerota fascia for management of inflammatory kidney. J Endourol. 2008;22(4):681–686. doi:10.1089/end.2007.0291

32. Manohar T, Desai M, Desai M. Laparoscopic nephrectomy for benign and inflammatory conditions. J Endourol. 2007;21(11):1323–1328. doi:10.1089/end.2007.9883

33. Mejean A, Vogt B, Quazza JE, Chretien Y, Dufour B. Mortality and morbidity after nephrectomy for renal cell carcinoma using a transperitoneal anterior subcostal incision. Eur Urol. 1999;36(4):298–302. doi:10.1159/000020008

34. Lefranc R, Waeckel T, Doerfler A, Tillou X. Emergency nephrectomy in surgical pyelonephritis: outcomes and predictors of conservative management failure. World J Urol. 2025;43(1):561. doi:10.1007/s00345-025-05900-1

35. Olcucuoglu E, Tonyali S, Tastemur S, et al. Comparison of long-term kidney functions after radical nephrectomy and simple nephrectomy. PeerJ. 2019;7:e6701. doi:10.7717/peerj.6701

36. Kasiske BL, Ma JZ, Louis TA, Swan SK. Long-term effects of reduced renal mass in humans. Kidney Int. 1995;48(3):814–819. doi:10.1038/ki.1995.355

38. Katz R, Pode D, Golijanin D, et al. Laparoscopic nephrectomy for infected, obstructed and non-functioning kidneys. Surg Laparosc Endosc Percutan Tech. 2004;14(6):340–343. doi:10.1097/01.sle.0000148466.25814.e1

48. Mosa H, Giannettoni A, Patil K, et al. Pediatric nephrectomy: comparison of perioperative outcomes of three different minimally invasive and open approaches. J Laparoendosc Adv Surg Tech A. 2021;31(12):1466–1470. doi:10.1089/lap.2021.0343

49. Beisland C, Medby PC, Sander S, Beisland HO. Nephrectomy — indications, complications and postoperative mortality in 646 consecutive patients. Eur Urol. 2000;37(1):58–64. doi:10.1159/000020101